[Corrigendum] New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer.

Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, in Fig. 3 on p. 1356 showing the results of cellular apoptosis experiments, the 'Doxy 5 µg/ml' and 'Doxy 10 µg/ml' data panels appeared to contain overlapping data, such that these images were apparently derived from the same original source where the results of differently performed experiments were intended to have been shown. In addition, in Fig. 4A on p. 1357, showing the results of TUNEL assay experiments, the 'Doxy 10 µg/ml' and '5‑FU 25 µg/ml' data panels contained overlapping sections, similarly suggesting that these data had been derived from the same original source. The authors were able to consult their original data, and recognized how these errors occurred. The corrected versions of Figs. 3 and 4, now showing the correct data for the 'Doxy 5 µg/ml' experiment in Fig. 3 and the '5‑FU 25 µg/ml' experiment in Fig. 4A, are shown below and on the next page. The authors regret the errors that were made during the compilation of the original figures, and are grateful to the editor of International Journal of Oncology for allowing them the opportunity to publish this Corrigendum. Note that the errors that were made in compiling this pair of figures did not have a significant impact on the conclusions reached in this study. All the authors agree with the publication of this corrigendum; furthermore, they apologize to the readership for any inconvenience caused. [International Journal of Oncology 48: 1353‑1360, 2016; DOI: 10.3892/ijo.2016.3375].